MAPT and Alzheimer disease: In addition, plasma phosphorylated tau 181 (P-tau181) strongly associates with PET Aβ load and differentiates AD from non-AD neurodegenerative diseases (Karikari et al., 2020); whereas total tau (T-tau) measures were slightly increased in AD in some studies (Pase et al., 2019).